Nutex Health reported third quarter 2026 revenue of $217.6 million and diluted EPS of $5.71, both exceeding analyst expectations despite a 18.7% year-over-year revenue decline. The decrease was primarily driven by a difficult comparison to the prior year, which benefited from significant one-time arbitration-related revenue adjustments.
Key Highlights
- Total patient visits at the Hospital Division surged 18.1% year-over-year to 54,622, driven by both new facility openings and 12.4% same-hospital growth.
- Results included a $52.3 million non-cash reduction in contract services expense due to updated estimates, which contributed approximately $4.83 to diluted EPS.
- The company maintained a strong liquidity profile, finishing the quarter with $249.9 million in cash and cash equivalents against $34.2 million in total long-term debt.